Background: Thalassemia major is one of the common genetic disorders in Egypt. Skin disorders are usually neglected and frequently underdiagnosed among these patients. Objective: This work aimed to study the frequency and pattern of skin manifestations in Egyptian children with b-thalassemia. Methods: Fifty-four b-thalassemia major patients being followed at the Hematology Clinic of BeniSuef University Hospital were selected to participate in this study. All patients underwent detailed history evaluation, clinical examination and laboratory investigations, including complete blood count and serum ferritin. All patients were examined by a dermatologist to record any skin disorders. Results: Pruritus (37%), scars (33.3%), hyperpigmentation (31.5%) and xerosis (22.2%) were the most common findings. We found significant relations between serum ferritin and the occurrence of scars, hyperpigmentation, xerosis and ephelides (p <0.05). Also, significant associations between use of deferoxamine and scars (p¼0.004), hyperpigmentation (p¼0.004), xerosis (p¼0.03) and ephelides (p¼0.042) were found. Conclusion: Skin disorders are frequent in Egyptian children with thalassemia major. Careful skin examination is required to provide early diagnosis.
b-thalassemia is the most common single-gene disorder worldwide, in which hemoglobin b-chain production is decreased. Today, the life expectancy of thalassemia patients is increased because of a variety of treatment methods; however, treatmentrelated complications have also increased [4] . Profound anemia and severe hemosiderosis cause functional and physiologic abnormalities in various organ systems [5] . To the best of our knowledge, only a few studies have investigated skin disorders in thalassemia major patients. Our study might be the first to be performed among Egyptian children.
The aim of this study was to determine cutaneous complications in children with thalassemia major.
P A T I E N T S A N D M E T H O D S
Fifty-four multiply transfused b-thalassemia major patients, with mean age of 7.6 6 1.2 years, being followed at the Hematology Clinic of Beni-Suef University Hospital were selected to participate in this study. Patients were diagnosed as thalassemia major based on clinical (all patients underwent regular transfusions and received at least eight blood transfusions per year) and hematological (absent or trace of Hb A and high percentage of Hb F) characteristics. Children with any skin abnormalities prior to the diagnosis of thalassemia were excluded.
Ethical clearance was obtained from the ethical committee of the hospital. All parents or caregivers of the participants provided informed consent.
All patients underwent detailed history evaluation, including age, sex, duration of illness, frequency of blood transfusion and type of chelation therapy. Clinical examination included anthropometric measurements, vital signs and presence of any complications. Laboratory investigations included complete blood count and serum ferritin.
All patients were examined by a single dermatologist to record any dermatological disorders. The patients did not complain about having any skin problems, but skin lesions were discovered on examination by the dermatologist.
Pityriasis alba is a relatively common skin disorder characterized by the presence of asymptomatic, superficial, hypopigmented macules with slight overlying scaling, located usually on the face, neck and shoulders [6] .
Ephelides (freckles) occur on sun-exposed areas, especially the face, in early life in children with Fitzpatrick type 1 or 2 skin. Ephelides are usually small, 1-3 mm in diameter, and can be light brown to dark brown, becoming paler in winter [7] .
Data were analyzed using the SPSS ver. 11.5 (SPSS Inc., Chicago, IL, USA). Microsoft Excel software program (2010) was used to tabulate the results and represent them graphically.
The chi-square test was used to compare qualitative variables. For quantitative non-parametric data, the Mann-Whitney test was used for comparing two independent groups. A p-value of less than 0.05 was considered to show a statistically significant result.
R E S U L T S
The demographic and laboratory data of the patients are shown in Tables 1 and 5 . A total of 54 patients were enrolled in the study, 33 (61.1%) of them were male and 21 (38.9%) were female. Their age ranged between 1.5 and 16 years. Their mean weight was 21.4 6 5.4 kg.
Most of the patients (48%) received iron chelation therapy with deferasirox, followed by deferiprone (27.8%) and deferoxamine (13%). They were treated with a single chelating drug. Sixteen patients underwent a splenectomy (29.6%), and hepatomegaly was found in 44 patients (81.5%).
Distribution of skin disorders detected in the studied patients is shown in Table 2 . Forty-seven (87%) of the 54 evaluated patients had a skin disorder. The most common skin finding was pruritus (37%), followed by scars (33.3%). Table 3 demonstrates the relationship between serum ferritin and different skin disorders. Patients with scars, hyperpigmentation and xerosis had significantly higher serum ferritin levels than patients without these findings (p < 0.001).
D I S C U S S I O N
Iron overload causes significant morbidity and mortality in patients with transfusion-dependent bthalassemia [8] . The higher standards of care in bthalassemia have led to a significant increase in the life expectancy in the severely affected patients. Enhanced years of survival have led to the unmasking of management-related complications, which were infrequently encountered [9] .
Pruritus, which occurred in 37% of our patients, was the most common cutaneous abnormality. Our finding is close to a Turkish study by Dogramaci et al. [5] , who found that 37.2% of thalassemia patients had pruritus.
The pathogenesis of pruritus is unknown. It might be due to release of histamine from tissue mast cells secondary to stimulation by iron deposits in the skin [10] .
In this study, scars were the second most frequently observed skin disorder (33.3%). Scars were hypopigmented, and the abdomen was the most frequently affected area, followed by the lower limbs. Six patients had scars caused by the deferoxamine pump. A previous study in Iran reported that scars occurred in 28% of thalassemia patients [11] .
We also found a significant correlation between scar formation and both serum ferritin (p < 0.001) and deferoxamine (p ¼ 0.004).
Slate-gray pigmentation is known to be very common in thalassemia major cases. It usually appears in the first decade of life and becomes progressively more intense. Skin pigmentation seems to be due to the melanophore-stimulating effect of raised plasma ACTH [12] .
In our study, 31.5% of the patients showed hyperpigmentation (Fig. 1) . Hyperpigmentation is generalized and particularly pronounced in the sun-exposed areas of the face and hands. Most of the affected patients had dark brown hyperpigmentation. Fekri et al. [13] have documented a prevalence rate of 65.3% for skin pigmentation in their patients with thalassemia.
Dry skin is known as xerosis (Fig. 2) . The condition is characterized by pruritic, dry, cracked and fissured skin with scaling. The appearance of xerotic skin is like cracked porcelain. These cracks or fissures are present because of epidermal water loss. The skin splits and cracks are deep enough to disrupt dermal capillaries and bleeding fissures may occur. Itching or pruritus occurs, leading to secondary lesions [14] .
The reported frequency of xerosis among thalassemia patients ranges between 34% and 53% of the evaluated patients [5, 11] , whereas 22% of our patients reported this symptom. This difference may be related to the prevailing climatic conditions. Ten of our patients (18.5%) had pityriasis alba. Low levels of serum copper may account for occurrence of pityriasis alba. Copper is indispensable to activate the tyrosinase in melanocytes, which is critical to melanin production [15] . Several studies reported reduced serum copper in thalassemia patients [16, 17] .
Several immunological defects have been found in thalassemia patients [18] . Repetition of transfusions for the treatment of thalassemia major provokes the patient's immune system and results in the production of anti-erythrocyte antibodies (alloantibodies and/or autoantibodies) [19] . Urticaria and contact dermatitis, which were seen in our patients (16.7% and 13%, respectively), could be explained in this way.
Our study ranked ephelides as the seventh most frequently observed disorder (14.8%), while Naderi et al. [20] reported it as the most common disorder seen in their patients (70.7%). Ephelides in thalassemia patients might be explained by iron deposition in the skin.
Skandalis et al. [21] screened adult b-thalassemia patients over a 10-year period for treatment-requiring skin disease episodes and their correlation with hematologic diagnoses and epidemiological and serological characteristics. They concluded that serum ferritin is a risk factor for generalized dermatoses. In our study, we found significant relations between serum ferritin and the occurrence of scars, hyperpigmentation, xerosis and ephelides (p < 0.05).
We found a significant association between use of deferoxamine and scar formation, hyperpigmentation, xerosis and ephelides (Table 4) . Taher et al. [22] reported that the most common side effects of deferoxamine were pain, tenderness, itching, erythema, swelling, induration, lipodystrophy and a burning sensation at the site of infusion.
In our study, pruritus was the most common disorder found in patients receiving deferasirox (12 patients, 46%). Other studies reported lower incidence of pruritus with deferasirox [23, 24] .
Reduction in serum zinc levels as a result of deferiprone therapy has been described by previous studies [25, 26] . This might be the cause of skin disorders found in thalassemia patients receiving deferiprone. Pruritus, scars, hyperpigmentation and xerosis were the most commonly encountered cutaneous disorders in our patients receiving deferiprone.
A major limitation of this study was the small number of the study population. C O N C L U S I O N Dermatological findings are frequent in Egyptian children with thalassemia major. The most common skin lesions in our patients were pruritus, scars, hyperpigmentation and xerosis. Careful skin examination of thalassemia patients is required to provide early diagnosis and a better quality of life.
